The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•14 April 2026•

1 min read

DarioHealth Appoints John R. Palumbo to Board to Drive Commercial Scaling

Key Facts

1DarioHealth appointed veteran healthcare executive John R. Palumbo to its Board of Directors.

2The appointment aims to accelerate commercial scaling by leveraging Palumbo's relationships with health systems and payers.

DarioHealth Corp. (NASDAQ: DRIO) has officially appointed veteran healthcare executive John R. Palumbo to its Board of Directors. The strategic appointment is designed to accelerate the company's commercial scaling by leveraging Palumbo's extensive network within health systems and payer organizations. With a proven track record in the digital health sector, Palumbo is expected to play a pivotal role in driving strategic growth and forming new commercial partnerships. Investors generally view the addition of seasoned industry leadership as a positive signal of corporate maturity and operational focus. This move aligns with DarioHealth's broader objectives to expand its market presence and realize long-term strategic value in the competitive digital health landscape.